We came across a bullish thesis on Johnson & Johnson on Max Dividends’s Substack. In this article, we will summarize the bulls’ thesis on JNJ. Johnson & Johnson's share was trading at $205.34 as of December 1st. JNJ’s trailing and forward P/E were 19.99 and 17.99 respectively according to Yahoo Finance.
[caption id="attachment_1108329" align="aligncenter" width="640"]Johnson & Johnson (J&J) is a global healthcare leader with three major divisions: pharmaceuticals, medical devices, and consumer health products. Pharmaceuticals...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.